Expression of the epidermal growth factor receptor family in normal and malignant urothelium

作者: Ranveig Rotterud , Jahn Marthin Nesland , Aasmund Berner , Sophie D. Fossa

DOI: 10.1111/J.1464-410X.2005.05497.X

关键词:

摘要: OBJECTIVE To compare the immunohistochemically assessed expression of epidermal growth factor receptor (EGFR) family in normal and malignant bladder urothelium, suggest new hypotheses about their function development progression transitional cell carcinoma (TCC). PATIENTS AND METHODS EGFR, ERBB2, ERBB3 ERBB4 were evaluated urothelium (NU, 15), primary non-metastasized invasive TCC (NMC, 19) TCCs with corresponding metastases (MC, 51, both specimens). RESULTS All NU samples expressed ERBB4, none ERBB2 two EGFR; all staining was uniform throughout layers. increased decreased from to carcinomas. There no difference between NMCs MCs but more EGFR than MC samples. associations T category, grade or survival. All combinations levels for four receptors detected, dominant profile. CONCLUSION We hypothesise that: (i) is important differentiation NU; (ii) up-regulated carcinogenesis urinary does not discriminate cancer without metastases; (iii) may be a marker indolent disease. A current hypothesis, that superficial layers do express thus protect basal cells mitogenic effect EGF, challenged.

参考文章(31)
Edward M. Messing, Patricia Hanson, Peter Ulrich, Edrogen Erturk, Epidermal growth factor--interactions with normal and malignant urothelium: in vivo and in situ studies. The Journal of Urology. ,vol. 138, pp. 1329- 1335 ,(1987) , 10.1016/S0022-5347(17)43593-2
Lemoine Nr, Gullick Wj, Plowman Gd, Selden C, Prigent Sa, Hughes Cm, Expression of the c-erbB-3 protein in normal human adult and fetal tissues. Oncogene. ,vol. 7, pp. 1273- 1278 ,(1992)
N.-H. Chow, Hsiao-Sheng Liu, Hsiao-Bai Yang, Shih-Huang Chan, Ih-Jen Su, Expression patterns of erbB receptor family in normal urothelium and transitional cell carcinoma. An immunohistochemical study. Virchows Archiv. ,vol. 430, pp. 461- 466 ,(1997) , 10.1007/S004280050056
Elli Ioachim, A. Charchanti, N. E. Stavropoulos, N. J. Agnantis, E. D. Athanassiou, A. Skopelitou, Immunohistochemical expression of retinoblastoma gene product (Rb), p53 protein, MDM2, c-erbB-2, HLA-DR and proliferation indices in human urinary bladder carcinoma. Histology and Histopathology. ,vol. 15, pp. 721- 727 ,(2000) , 10.14670/HH-15.721
M.J. Mihatsch, F. Gudat, F. Waldman, D. Moore, P. Carroll, G. Sauter, H. Moch, R. Kerschmann, K. Chew, Heterogeneity of erbB-2 Gene Amplification in Bladder Cancer Cancer Research. ,vol. 53, pp. 2199- 2203 ,(1993)
Tzong-Shin Tzai, Chung-Liang Ho, Hsiao-Sheng Liu, Shih-Huang Chan, Nan-Haw Chow, Expression Profiles of ErbB Family Receptors and Prognosis in Primary Transitional Cell Carcinoma of the Urinary Bladder Clinical Cancer Research. ,vol. 7, pp. 1957- 1962 ,(2001)
B GUSTERSON, G COWLEY, J SMITH, B OZANNE, Cellular localisation of human epidermal growth factor receptor. Cell Biology International Reports. ,vol. 8, pp. 649- 658 ,(1984) , 10.1016/0309-1651(84)90045-6
A M Nouri, C Thompson, H Cannell, M Symes, S Purkiss, Z Amirghofran, Profile of epidermal growth factor receptor (EGFr) expression in human malignancies: effects of exposure to EGF and its biological influence on established human tumour cell lines. International Journal of Molecular Medicine. ,vol. 6, pp. 495- 500 ,(2000) , 10.3892/IJMM.6.4.495
Meral Koyuncuoğlu, Aydanur Kargı, Sultan Cingöz, Ziya Kırkalı, Investigation of p53, c-erbB-2, PCNA immunoreactivity, DNA content, AgNOR and apoptosis in bladder carcinoma as prognostic parameters Cancer Letters. ,vol. 126, pp. 143- 148 ,(1998) , 10.1016/S0304-3835(97)00532-6